title: Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior.
abstract: Inflammatory molecules, such as cyclooxygenase (COX), a prostaglandin synthetic enzyme, have been identified as a marker of depressive symptomology. Previously, we have observed elevated basal COX-2 expression in the hypothalamus of adult male rats treated neonatally with lipopolysaccharide (LPS), which might suggest a phenotype for disrupted hedonic behavior, a symptom of depression. However, COX-2 and its contribution to the expression of anhedonic behavior has not been investigated in these males or in female rats across the estrous cycle, which is the purpose of the current work. Here, we examine the effects of a neonatal LPS challenge or saline on the sucrose preference test as a measure of anhedonia, and hypothalamic COX-2 expression, in adult male and freely cycling female rats. Our data indicate a sex difference in that neonatal LPS at postnatal d 14 causes elevated basal expression of hypothalamic COX-2 in male, but not in female, rats. Additionally, baseline sucrose preference in male and female rats was unaltered as a function of neonatal LPS treatment or estrous cycle stage. In both male and female animals, 50 microg/kg LPS in adulthood caused elevated plasma IL-6 and hypothalamic COX-2 expression in neonatally saline-treated rats but significantly less so in neonatally LPS-treated rats of both sexes; this neonatal programming was not evident for sucrose preference or for total fluid intake (even after much higher doses of LPS). Our data are suggestive of a dissociation between inflammation and anhedonic behavior and a differential effect of neonatal inflammation in males and females.
authors.affiliation: Department of Physiology and Pharmacology, Hotchkiss Brain Institute, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N 4N1. ackentne@ucalgary.ca
authors.forename: A C
authors.initials: AC
authors.lastname: Kentner
authors.forename: S A
authors.initials: SA
authors.lastname: McLeod
authors.forename: E F
authors.initials: EF
authors.lastname: Field
authors.forename: Q J
authors.initials: QJ
authors.lastname: Pittman
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D051546:Cyclooxygenase 2 / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D030762:Estrous Cycle / Q000187:drug effects; D005260:Female; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007249:Inflammation / Q000097:blood / Q000139:chemically induced / Q000378:metabolism*; D015850:Interleukin-6 / Q000097:blood; D008070:Lipopolysaccharides / Q000633:toxicity; D008297:Male; D011247:Pregnancy; D051381:Rats; D012737:Sex Factors
chemical_list: D015850:Interleukin-6; D008070:Lipopolysaccharides; D051546:Cyclooxygenase 2
references.citation: Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):659-63
references.pmid: 11509229
references.citation: J Neurosci. 2008 Sep 3;28(36):9055-65
references.pmid: 18768700
references.citation: Psychopharmacology (Berl). 1989;98(3):408-11
references.pmid: 2501818
references.citation: Neuropsychopharmacology. 2006 Sep;31(9):1910-8
references.pmid: 16395304
references.citation: Brain Res Mol Brain Res. 1998 May;56(1-2):45-56
references.pmid: 9602052
references.citation: Epilepsia. 2004 Nov;45(11):1317-29
references.pmid: 15509232
references.citation: Psychoneuroendocrinology. 1981;6(1):81-90
references.pmid: 7195598
references.citation: Endocrinology. 2005 Apr;146(4):1650-73
references.pmid: 15618360
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):761-70
references.pmid: 15878621
references.citation: Cell Biol Int. 1996 Oct;20(10):687-92
references.pmid: 8969462
references.citation: Mol Psychiatry. 2002;7(8):845-50
references.pmid: 12232777
references.citation: Psychoneuroendocrinology. 2009 Nov;34(10):1515-25
references.pmid: 19524372
references.citation: Pharmacogenomics J. 2006 Nov-Dec;6(6):381-7
references.pmid: 16568149
references.citation: FASEB J. 2005 Sep;19(11):1519-21
references.pmid: 15972802
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1215-21
references.pmid: 16809485
references.citation: Eur J Neurosci. 2008 Feb;27(3):644-53
references.pmid: 18279317
references.citation: Psychopharmacology (Berl). 2003 Dec;170(4):399-408
references.pmid: 12955300
references.citation: Am J Physiol. 1990 Mar;258(3 Pt 2):R798-803
references.pmid: 2316725
references.citation: Physiol Behav. 2009 May 25;97(2):270-7
references.pmid: 19268677
references.citation: Brain Behav Immun. 2009 Oct;23(7):977-85
references.pmid: 19464359
references.citation: Eur J Pharmacol. 2009 Jun 10;612(1-3):54-60
references.pmid: 19356723
references.citation: Hum Psychopharmacol. 2008 Mar;23(2):87-94
references.pmid: 18172906
references.citation: Curr Biol. 2008 Feb 12;18(3):195-9
references.pmid: 18261909
references.citation: Brain Behav Immun. 2008 Nov;22(8):1160-72
references.pmid: 18562160
references.citation: Pharmacol Biochem Behav. 2003 Aug;76(1):153-9
references.pmid: 13679228
references.citation: Physiol Behav. 1971 Feb;6(2):115-26
references.pmid: 5125467
references.citation: Neuropsychopharmacology. 2001 May;24(5):531-44
references.pmid: 11282253
references.citation: Depress Anxiety. 2009;26(7):607-11
references.pmid: 19496103
references.citation: Behav Brain Res. 2005 Nov 7;164(2):231-8
references.pmid: 16125259
references.citation: Pain. 2005 Dec 15;119(1-3):133-141
references.pmid: 16297551
references.citation: Psychoneuroendocrinology. 2007 Jun;32(5):516-31
references.pmid: 17482371
references.citation: Brain Res. 1996 Mar 4;711(1-2):163-74
references.pmid: 8680860
references.citation: Behav Brain Res. 2006 Apr 25;169(1):39-47
references.pmid: 16413067
references.citation: Life Sci. 1995;57(11):1011-26
references.pmid: 7658909
references.citation: Prog Brain Res. 2000;122:81-103
references.pmid: 10737052
references.citation: J Neurosci. 2008 Jul 2;28(27):6904-13
references.pmid: 18596165
references.citation: Neuroimmunomodulation. 2001;9(3):163-9
references.pmid: 11752890
references.citation: Endocrinology. 2003 Jun;144(6):2454-60
references.pmid: 12746307
references.citation: Birth Defects Res B Dev Reprod Toxicol. 2007 Apr;80(2):84-97
references.pmid: 17342777
references.citation: Behav Brain Res. 2004 Feb 4;149(1):77-85
references.pmid: 14739012
references.citation: J Neurosci. 1995 Jan;15(1 Pt 1):376-84
references.pmid: 7823142
references.citation: Mol Psychiatry. 2006 Jul;11(7):680-4
references.pmid: 16491133
references.citation: J Neurosci. 2004 May 26;24(21):4928-34
references.pmid: 15163684
references.citation: Brain Behav Immun. 2006 Jul;20(4):325-30
references.pmid: 16226008
references.citation: Behav Neurosci. 2005 Feb;119(1):293-301
references.pmid: 15727533
references.citation: Psychoneuroendocrinology. 2009 Apr;34(3):343-52
references.pmid: 18977603
references.citation: Eur J Neurosci. 2007 May;25(10):3091-8
references.pmid: 17561822
references.citation: Behav Brain Res. 2007 Jun 18;180(2):161-73
references.pmid: 17433456
references.citation: J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):300-6
references.pmid: 18430566
references.citation: Braz J Biol. 2002 Nov;62(4A):609-14
references.pmid: 12659010
references.citation: Stress. 2007 Aug;10(3):283-93
references.pmid: 17613942
references.citation: Neuropsychopharmacology. 2006 Jan;31(1):129-38
references.pmid: 15920500
references.citation: Neurotoxicol Teratol. 2007 Mar-Apr;29(2):255-63
references.pmid: 17169529
references.citation: Trends Pharmacol Sci. 1992 Jan;13(1):24-8
references.pmid: 1542935
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Aug;293(2):R581-9
references.pmid: 17507437
references.citation: Psychoneuroendocrinology. 2008 Apr;33(3):261-9
references.pmid: 18164556
references.citation: J Neuroinflammation. 2008 May 13;5:15
references.pmid: 18477398
references.citation: Pharmacol Biochem Behav. 2003 Aug;76(1):9-16
references.pmid: 13679212
references.citation: J Neuroendocrinol. 2009 Aug;21(8):683-9
references.pmid: 19500221
references.citation: Drug Alcohol Depend. 2007 Jul 10;89(2-3):183-9
references.pmid: 17240083
references.citation: Psychopharmacology (Berl). 2005 May;179(2):356-65
references.pmid: 15565429
references.citation: Neurosci Biobehav Rev. 1988 Summer;12(2):123-37
references.pmid: 3050629
references.citation: Proc Soc Exp Biol Med. 1983 Jul;173(3):319-23
references.pmid: 6346326
references.citation: Pharmacol Biochem Behav. 2006 Jul;84(3):429-35
references.pmid: 16844207
references.citation: Am J Physiol Regul Integr Comp Physiol. 2006 Nov;291(5):R1316-26
references.pmid: 16809483